Persistence of hepatitis B surface antigen in blood in a chronic haemodialysis patient following vaccination booster

BMJ Case Reports

Volumn , Issue , 2014, Pages

  Calisti, Giorgio ^a   Herman, Omar ^a   Powley, Michelle ^a   Haque, Tanzina ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CHEMILUMINESCENCE IMMUNOASSAY; DEATH; DRUG RESPONSE; FOLLOW UP; HEMODIALYSIS PATIENT; HEPATITIS B; HIGH RISK PATIENT; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; VIRUS LOAD;

EID: 84902579108     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2013-202191     Document Type: Article

References (14)

1. Edey M, Barraclough K, Johnson DW. Review article: hepatitis B and dialysis. Nephrology (Carlton) 2010;15:137-45.
2. Ribot S, Rothstein M, Goldblat M, et al. Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients. Arch Intern Med 1979;139:178-80. (Pubitemid 10132266)
3. Geddes C, Lindley E, Duncan N. Renal association clinical practice guideline on prevention of blood borne virus infection in the renal unit. Nephron Clin Pract 2011;118:c165-88.
4. Lanini S, Puro V, Lauria FN, et al. Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007. BMC Med 2009;7:15.
5. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol 2006;78:169-77. (Pubitemid 43132560)
6. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999;33:356-60. (Pubitemid 29072240)
7. Ly D, Yee HF Jr, Brezina M, et al. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol 2002;97:138-41. (Pubitemid 34059777)
8. Tacke F, Amini-Bavil-Olyaee S, Heim A, et al. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient. J Clin Virol 2007;38:353-7. (Pubitemid 46414002)
9. Abushady EA, Gameel MM, Klena JD, et al. HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt. World J Hepatol 2011;3:147-56.
10. Katkov WN, Ault MJ, Dubin SB. Absence of hepatitis B surface antigenemia after vaccination. Arch Pathol Lab Med 1989;113:1290. (Pubitemid 19275693)
11. Koksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr 1996;85:1501-2. (Pubitemid 26411418)
12. Kloster B, Kramer R, Eastlund T, et al. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995;35:475-7.
13. Rysgaard CD, Morris CS, Drees D, et al. Positive hepatitis B surface antigen tests due to recent vaccination: a persistent problem. BMC Clin Pathol 2012;12:15.
14. Santana Rodriguez OE, Morillas Jarillo C, Esparza Martin N, et al. [Transient blood surface antigens of hepatitis B in patients on hemodialysis]. Rev Clin Esp 1999;199:198-201.